146 related articles for article (PubMed ID: 15003240)
1. From targets to targeted treatment solutions.
Davies N; Peakman T; Arlington S
Drug Discov Today; 2004 Mar; 9(6):245-7. PubMed ID: 15003240
[No Abstract] [Full Text] [Related]
2. Drug life-cycle technologies.
Fleming E; Ma P
Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
[No Abstract] [Full Text] [Related]
3. [Chemical drug development].
Castro B
Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592
[No Abstract] [Full Text] [Related]
4. Combinatorial chemistry at the crossroads.
Whitehead RS
Nat Biotechnol; 1998 Jan; 16(1):2-3. PubMed ID: 9447574
[No Abstract] [Full Text] [Related]
5. Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
Dixon J; Lawton G; Machin P
Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701
[No Abstract] [Full Text] [Related]
6. Looking forward in pharmaceutical process chemistry.
Davies IW; Welch CJ
Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
[TBL] [Abstract][Full Text] [Related]
7. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
Schirlin D; Galvan M; Le Fur G
Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
[TBL] [Abstract][Full Text] [Related]
8. Life beyond synthesis.
Russo E
Nature; 2003 Jul; 424(6948):594-6. PubMed ID: 12891371
[No Abstract] [Full Text] [Related]
9. Foundation Review: Transgenic animals and their impact on the drug discovery industry.
Dunn DA; Pinkert CA; Kooyman DL
Drug Discov Today; 2005 Jun; 10(11):757-67. PubMed ID: 15922934
[TBL] [Abstract][Full Text] [Related]
10. Mastering medicinal chemistry: strategies, issues and success stories.
Lindsley CW
Drug Discov Today; 2004 Aug; 9(16):695-6. PubMed ID: 15341782
[No Abstract] [Full Text] [Related]
11. The role of medicinal chemists in drug discovery.
Greenlee WJ; Desai MC
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):419-20. PubMed ID: 16022177
[No Abstract] [Full Text] [Related]
12. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
13. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
14. Highlighting the new advances in drug discovery and development.
Taliani S; Da Settimo F
ChemMedChem; 2008 Jan; 3(1):181-4. PubMed ID: 18022978
[No Abstract] [Full Text] [Related]
15. Michael Hanson.
Hanson M
Nat Rev Drug Discov; 2016 Feb; 15(2):80. PubMed ID: 26837587
[No Abstract] [Full Text] [Related]
16. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Fitzgerald GA
Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453
[TBL] [Abstract][Full Text] [Related]
17. An interview with Richard M. Eglen, Ph.D.
Eglen RM
Assay Drug Dev Technol; 2006 Oct; 4(5):503-9. PubMed ID: 17115921
[No Abstract] [Full Text] [Related]
18. Does chemistry have a future in therapeutic innovations?
Meunier B
Angew Chem Int Ed Engl; 2012 Aug; 51(35):8702-6. PubMed ID: 22777842
[No Abstract] [Full Text] [Related]
19. Where will we get the next generation of medicinal chemists?
Allen D
Drug Discov Today; 2016 May; 21(5):704-6. PubMed ID: 27131748
[No Abstract] [Full Text] [Related]
20. Key factors in the rising cost of new drug discovery and development.
Dickson M; Gagnon JP
Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
[No Abstract] [Full Text] [Related]
[Next] [New Search]